carbostyril has been researched along with Tremor in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwankhaus, J; Singh, S | 1 |
| Assuncao-Talbott, S; Blumer, J; Boulton, DW; Findling, RL; Iwamoto, T; Kauffman, R; Kollia, G; Kornhauser, DM; Mallikaarjun, S; McQuade, RD; Sahasrabudhe, V; Salazar, DE; Sallee, FR; Vachharajani, NN | 1 |
| Rittmannsberger, H; Werl, R | 1 |
| Decramer, ML; Hanania, NA; Lötvall, JO; Yawn, BP | 1 |
1 review(s) available for carbostyril and Tremor
| Article | Year |
|---|---|
The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Blood Glucose; Cough; Ethanolamines; Formoterol Fumarate; Headache; Humans; Indans; Nasopharyngitis; Potassium; Pulmonary Disease, Chronic Obstructive; Quinolones; Respiratory Tract Infections; Salmeterol Xinafoate; Spasm; Tachycardia; Tremor | 2013 |
3 other study(ies) available for carbostyril and Tremor
| Article | Year |
|---|---|
Olfactory disturbance in Parkinson disease.
Topics: Aged; Anticonvulsants; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Biomarkers; Brain; Cognition Disorders; Constipation; Diagnosis, Differential; Disease Progression; Electroencephalography; Hallucinations; Humans; Levetiracetam; Lewy Body Disease; Male; Olfactory Pathways; Parkinson Disease; Piperazines; Piracetam; Quinolones; REM Sleep Behavior Disorder; Treatment Failure; Tremor | 2009 |
An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Child; Conduct Disorder; Female; Follow-Up Studies; Humans; Male; Piperazines; Prospective Studies; Quinolones; Tremor; Vomiting | 2009 |
Does aripiprazole protect from serotonin syndrome?
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Tremor; Venlafaxine Hydrochloride; Young Adult | 2012 |